CH678487A5 - Cosmetic compsn. for reviving skin - contg. placental extract, thymus peptide(s) high mol.wt. DNA, flavonoid(s) and saponin(s) - Google Patents

Cosmetic compsn. for reviving skin - contg. placental extract, thymus peptide(s) high mol.wt. DNA, flavonoid(s) and saponin(s) Download PDF

Info

Publication number
CH678487A5
CH678487A5 CH1931/89A CH193189A CH678487A5 CH 678487 A5 CH678487 A5 CH 678487A5 CH 1931/89 A CH1931/89 A CH 1931/89A CH 193189 A CH193189 A CH 193189A CH 678487 A5 CH678487 A5 CH 678487A5
Authority
CH
Switzerland
Prior art keywords
sep
extract
weight
dna
composition according
Prior art date
Application number
CH1931/89A
Other languages
French (fr)
Inventor
Pierre Bottiglieri
Original Assignee
Givenchy Parfums
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Givenchy Parfums filed Critical Givenchy Parfums
Priority to CH1931/89A priority Critical patent/CH678487A5/en
Publication of CH678487A5 publication Critical patent/CH678487A5/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9755Gymnosperms [Coniferophyta]
    • A61K8/9761Cupressaceae [Cypress family], e.g. juniper or cypress
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/70Biological properties of the composition as a whole
    • A61K2800/72Hypo-allergenic

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Cosmetics (AREA)

Abstract

Cosmetic compsn. for reviving 'tired' skin contains, as active ingredients, a biocomplex (A) contg. placental extract, thymus peptides and highly polymerised DNA, plus a mixt. of plant extract contg. flavonoids and saponins. Pref. (A) is present at 1-5 (2.5) wt.% and comprises (by wt.) 4-12 (8)% bovine or ovine placental extract; 4-12 (8)% calf thymus peptides; 0.5-3 (2)% DNA of mol. wt. over 1 million, and the balance water. The compsns. contain 0.1-1 (0.25)% each of horsechestnut extract (flavonoids) and Ruscus extract (saponins) and may also include a mixt. of aromatic components consisting of oils fo cloves, rose, cedarwood, geranium, patchooli, sandalwood and rosewood, plus vanilla and jasmine. USE/ADVANTAGE - The compsn. stimulates cellular metabolism, cell multiplication and cutaneous microcirculation; and prevents aging of the skin caused by free radicals, etc. The highly polymerised DNA has a better moisturising action than DNA normally used and also has some healing effect. The valvonoids act as vasoconstrictor, and the saponins as astringent and to counteract redness. The compsns. are not irritating and are hypoallergenic.

Description

       

  
 



  La présente invention se rapporte à une composition cosmétique défatigante, plus particulièrement sous la forme d'un gel contenant des principes actifs d'origine naturelle. 



  Depuis quelques années, on utilise en cosmétologie de l'acide désoxyribonucléique (ADN), polymère naturel qui présente des propriétés intéressantes à l'égard des cellules et des tissus de la peau notamment. L'activité cosmétologique de l'ADN étant toutefois limitée, il s'est révélé important de rechercher de nouveaux composés ou mélanges de composés d'origine naturelle qui permettent d'obtenir de meilleurs résultats notamment pour améliorer le métabolisme cellulaire, favoriser la multiplication des cellules, améliorer la microcirculation cutanée, prévenir les attaques du vieillissement de la peau en neutralisant les effets néfastes des radicaux libres, etc. 



  L'objet de la présente invention, visant à atteindre le but précité, consiste en une composition cosmétique qui comporte à titre de principes actifs un biocomplexe contenant un extrait placentaire, des peptides thymiques et de l'acide desoxyribonucléique hautement polymérisé, ainsi qu'un mélange d'extraits de végétaux contenant notamment des flavonoïdes et des saponines. 



  Selon une forme préférée de l'invention, la composition cosmétique comporte de 1 à 5% poids du biocomplexe, de préférence environ 2,5%, de 0,1 à 1% poids d'extrait de marron d'Inde contenant des flavonoïdes, de préférence environ 0,25%, et de 0,1 à 1% poids d'extrait de petit houx (= ruscus) contenant des saponines, de préférence environ 0,25%. 



  Egalement selon une forme préférée de l'invention, le biocomplexe est formé de 4 à 12% poids, de préférence environ 8% d'extrait placentaire, par exemple bovin ou ovin, de 4 à 12%, de préférence environ 8%, de peptides thymiques, par exemple de veaux, de 0,5 à 3%, de préférence environ 2%, d'ADN hp (poids moléculaire supérieur à 1 million), le reste étant de l'eau. 



  Il a été démontré que les extraits placentaires et les peptides thymiques améliorent le métabolisme cellulaire en augmentant la consommation d'oxygène, alors que l'ADN hp favorise la régénération tissulaire et présente un pouvoir hydratant supérieur à l'ADN habituellement utilisé; il peut également avoir un certain pouvoir cicatrisant. On peut obtenir de l'ADN hp par exemple à partir de laitance de poisson. Des tests ont d'ailleurs mis en évidence l'efficacité conjuguée de ces extraits biologiques. 



  Des tests in vitro ont tout d'abord montré que le biocomplexe permet un accroissement de 120% de la consommation en oxygène (méthode: test de Warburg), ce qui se traduit par une augmentation de la respiration cellulaire et par une activation du métabolisme (utilisation des éléments nutritifs et élimination des toxines accélérées). Egalement in vitro, il a été démontré que le biocomplexe permet une stimulation de la croissance des fibroplastes de 265 à 324%. Enfin, des tests réalisés in vitro sur l'homme par la technique dite de "Fluvographie" ont prouvé une amélioration de 15% de la microcirculation cutanée. 



  D'autre part, l'extrait de marron d'Inde, notamment grâce à la présence de flavonoïdes, est un tonique vasculaire, car il active la microcirculation des capillaires sanguins par effet vasoconstricteur. 



  Quant à l'extrait de petit houx ou ruscus, riche en saponines, il possède des propriétés contre les rougeurs diffuses, et est un agent astringent. Il est surtout employé en traitement préventif des peaux délicates et facilement irritables. 



  La combinaison du biocomplexe et des extraits végétaux permet de conférer à la composition cosmétique selon l'invention un effet relaxant et défatigant; plus particulièrement, cette composition lorsqu'elle est appliquée sur la peau, lisse et détend les traits, décongestionne l'épiderme en activant la microcirculation, favorise la régénération cellulaire, maintient l'équilibre hydrique de l'épiderme et procure une sensation de fraîcheur. 



  La composition cosmétique selon l'invention peut en outre incorporer un mélange de composés aromatiques, destiné à conférer une odeur discrète à ladite composition, sans toutefois modifier ses caractéristiques, ni y ajouter de constituants alcooliques. Ce mélange de composés aromatiques, par exemple solubilisé dans de l'huile de ricin hydrogénée, peut contenir des essences de girofle, de rose, de bois de cèdre, de géranium, de patchouli, de bois de santal et de bois de rose, ainsi que des absolues de vanille et de jasmin (ci-après CA). 



  L'invention sera maintenant décrite plus en détail et illustrée en référence à l'exemple suivant. Dans cet exemple, le biocomplexe (BC) a la composition suivante: 8% d'extrait placentaire, 8% de peptides thymiques, 2% d'ADN hp, le reste étant de l'eau. De plus, la plupart des termes utilisés dans la formulation sont conformes au dictionnaire de la CTFA (Cosmetics Toilet Fragrances Association/USA). 


 Exemple 
 


 Gel relaxant 
 
<tb><TABLE> Columns=3 
<tb> <SEP>Composition:

  <SEP>BC <SEP>2,5% poids 
<tb> <SEP>Extrait de petit houx <SEP>0,25 
<tb> <SEP>Extrait de marron d'Inde <SEP>0,25 
<tb> <SEP>Alcool éthylique <SEP>2,0 
<tb> <SEP>Carbomer* <SEP>0,8 
<tb> <SEP>Composés aromatiques <SEP>0,06 
<tb> <SEP>Huile de ricin hydrogénée <SEP>1,2 
<tb> <SEP>Phenonip** <SEP>0,45 
<tb> <SEP>Déhydroacétate de Na <SEP>0,1 
<tb> <SEP>Lysine <SEP>1,2 
<tb> <SEP>Cocoate de glycéryle-polyéthylèneglycol <SEP>3,0 
<tb> <SEP>Diméthicone-copolyol <SEP>1,0 
<tb> <SEP>Colorant <SEP>0,012 
<tb> <SEP>Eau déminéralisée <SEP>ad. 100 
 * Carbomer ou Carbopol: polymère carboxyvinylique
** Phenonip: mélange de phénoxyéthanol et de méthyl-, éthyl-, propyl- et butylparabène
  
<tb></TABLE> 


 Préparation: 
 



  On prépare tout d'abord un gel de carbomer en le dispersant lentement dans l'eau chaude (env. 75 DEG C) et on l'introduit dans un réacteur. Une légère agitation est maintenue, tout en contrôlant le gradient de refroidissement vers 2-5 DEG C/min., un vide de l'ordre de -0,8 à -1,0 bar étant maintenu dans le réacteur. A 40 DEG C, on introduit les composés aromatiques préalablement dissous dans l'huile de ricin hydrogéné. Puis l'on procède à une neutralisation par adjonction lente de lysine en solution aqueuse (50%), et l'on ajoute le cocoate de glycéryle-polyéthylèneglycol, les principes actifs en solution dans un mélange  eau/alcool et le dérivé siliconé, en vérifiant après chaque adjonction l'homogénéité de la dispersion. Enfin, on introduit les conservateurs et le colorant. 



    On obtient ainsi un gel qui peut être conditionné en flaconpompe doseur, et utilisé de manière avantageuse en l'appliquant sur la peau dès que celle-ci manifeste des signes de fatigue ou bien comme préparation au maquillage. 



  Enfin, la composition cosmétique selon l'invention et plus particulièrement celle décrite précédemment à titre d'exemple, a été soumise avec succès aux tests usuels pour prouver qu'elle ne produit aucune irritation cutanée. D'autre part, d'autres tests ont été effectués, qui ont démontré que cette composition est hypoallergénique. 



  
 



  The present invention relates to a defatigating cosmetic composition, more particularly in the form of a gel containing active principles of natural origin.



  In recent years, deoxyribonucleic acid (DNA) has been used in cosmetology, a natural polymer which has interesting properties with regard to skin cells and tissues in particular. However, the cosmetological activity of DNA being limited, it has proved important to search for new compounds or mixtures of compounds of natural origin which make it possible to obtain better results, in particular for improving cell metabolism, promoting the multiplication of cells, improve skin microcirculation, prevent attacks of skin aging by neutralizing the harmful effects of free radicals, etc.



  The object of the present invention, aimed at achieving the above object, consists of a cosmetic composition which comprises as active principles a biocomplex containing a placental extract, thymic peptides and highly polymerized deoxyribonucleic acid, as well as a mixture of plant extracts containing in particular flavonoids and saponins.



  According to a preferred form of the invention, the cosmetic composition comprises from 1 to 5% by weight of the biocomplex, preferably approximately 2.5%, from 0.1 to 1% by weight of horse chestnut extract containing flavonoids, preferably about 0.25%, and 0.1 to 1% by weight of small holly extract (= ruscus) containing saponins, preferably about 0.25%.



  Also according to a preferred form of the invention, the biocomplex is formed from 4 to 12% by weight, preferably about 8% of placental extract, for example bovine or sheep, from 4 to 12%, preferably about 8%, thymic peptides, for example from calves, from 0.5 to 3%, preferably about 2%, of hp DNA (molecular weight greater than 1 million), the rest being water.



  It has been shown that placental extracts and thymic peptides improve cell metabolism by increasing oxygen consumption, while hp DNA promotes tissue regeneration and has a higher hydrating power than DNA usually used; it can also have some healing power. One can obtain hp DNA for example from milt from fish. Tests have also demonstrated the combined effectiveness of these biological extracts.



  In vitro tests first showed that the biocomplex allows a 120% increase in oxygen consumption (method: Warburg test), which results in an increase in cellular respiration and an activation of metabolism ( use of nutrients and elimination of accelerated toxins). Also in vitro, the biocomplex has been shown to stimulate fibroplast growth from 265 to 324%. Finally, tests carried out in vitro on humans using the so-called "Fluvography" technique have shown a 15% improvement in skin microcirculation.



  On the other hand, horse chestnut extract, in particular thanks to the presence of flavonoids, is a vascular tonic, because it activates the microcirculation of blood capillaries by vasoconstrictor effect.



  As for the extract of small holly or ruscus, rich in saponins, it has properties against diffuse redness, and is an astringent. It is especially used in preventive treatment of delicate and easily irritable skin.



  The combination of the biocomplex and plant extracts makes it possible to give the cosmetic composition according to the invention a relaxing and tiring effect; more particularly, this composition when applied to the skin, smoothes and relaxes the features, decongests the epidermis by activating the microcirculation, promotes cell regeneration, maintains the water balance of the epidermis and provides a feeling of freshness.



  The cosmetic composition according to the invention can also incorporate a mixture of aromatic compounds, intended to impart a discreet odor to said composition, without however modifying its characteristics, or adding alcoholic constituents thereto. This mixture of aromatic compounds, for example dissolved in hydrogenated castor oil, can contain cloves, rose, cedar, geranium, patchouli, sandalwood and rosewood, as well than vanilla and jasmine absolutes (hereafter CA).



  The invention will now be described in more detail and illustrated with reference to the following example. In this example, the biocomplex (BC) has the following composition: 8% of placental extract, 8% of thymic peptides, 2% of hp DNA, the rest being water. In addition, most of the terms used in the formulation conform to the dictionary of the CTFA (Cosmetics Toilet Fragrances Association / USA).


 Example
 


 Relaxing gel
 
<tb> <TABLE> Columns = 3
<tb> <SEP> Composition:

  <SEP> BC <SEP> 2.5% by weight
<tb> <SEP> Small holly extract <SEP> 0.25
<tb> <SEP> Horse chestnut extract <SEP> 0.25
<tb> <SEP> Ethyl alcohol <SEP> 2.0
<tb> <SEP> Carbomer * <SEP> 0.8
<tb> <SEP> Aromatic compounds <SEP> 0.06
<tb> <SEP> Hydrogenated castor oil <SEP> 1,2
<tb> <SEP> Phenonip ** <SEP> 0.45
<tb> <SEP> Na dehydroacetate <SEP> 0.1
<tb> <SEP> Lysine <SEP> 1,2
<tb> <SEP> Glyceryl-polyethylene glycol cocoate <SEP> 3.0
<tb> <SEP> Dimethicone-copolyol <SEP> 1.0
<tb> <SEP> Dye <SEP> 0.012
<tb> <SEP> Demineralized water <SEP> ad. 100
 * Carbomer or Carbopol: carboxyvinyl polymer
** Phenonip: mixture of phenoxyethanol and methyl-, ethyl-, propyl- and butylparaben
  
<tb> </TABLE>


 Preparation:
 



  First prepare a carbomer gel by slowly dispersing it in hot water (approx. 75 DEG C) and introducing it into a reactor. Slight stirring is maintained, while controlling the cooling gradient towards 2-5 DEG C / min., A vacuum of the order of -0.8 to -1.0 bar is maintained in the reactor. At 40 DEG C, the aromatic compounds previously dissolved in the hydrogenated castor oil are introduced. Then neutralization is carried out by slow addition of lysine in aqueous solution (50%), and glyceryl-polyethylene glycol cocoate, the active ingredients in solution in a water / alcohol mixture and the silicone derivative are added. checking the homogeneity of the dispersion after each addition. Finally, the preservatives and the coloring agent are introduced.



    A gel is thus obtained which can be packaged in a pump dispenser bottle and used advantageously by applying it to the skin as soon as the latter shows signs of fatigue or else as a preparation for make-up.



  Finally, the cosmetic composition according to the invention and more particularly that described above by way of example, has been successfully subjected to the usual tests to prove that it does not produce any skin irritation. On the other hand, other tests have been carried out, which have demonstrated that this composition is hypoallergenic.


    

Claims (5)

1. Composition cosmétique défatigante comportant à titre de principes actifs un biocomplexe contenant un extrait placentaire, des peptides thymiques et de l'acide désoxyribonucléique hautement polymérisé, ainsi qu'un mélange d'extraits de végétaux contenant des flavonoïdes et des saponines.       1. Anti-fatigue cosmetic composition comprising as active principles a biocomplex containing a placental extract, thymic peptides and highly polymerized deoxyribonucleic acid, as well as a mixture of plant extracts containing flavonoids and saponins. 2. Composition selon la revendication 1, caractérisée par le fait qu'elle comporte de 1 à 5% poids du biocomplexe, de préférence environ 2,5%, de 0,1 à 1% poids d'extrait de marron d'Inde contenant des flavonoïdes, de préférence environ 0,25%, et de 0,1 à 1% poids d'extrait de petit houx (=ruscus) contenant des saponines, de préférence environ 0,25%. 2. Composition according to claim 1, characterized in that it comprises from 1 to 5% by weight of the biocomplex, preferably about 2.5%, from 0.1 to 1% by weight of horse chestnut extract containing flavonoids, preferably about 0.25%, and 0.1 to 1% by weight of small holly extract (= ruscus) containing saponins, preferably about 0.25%. 3. 3. Composition selon la revendication 2, caractérisée par le fait que le biocomplexe est formé de 4 à 12% poids, de préférence environ 8%, d'extrait placentaire, par exemple bovin ou ovin, de 4 à 12%, de préférence environ 8%, de peptides thymiques, par exemple de veaux, de 0,5 à 3%, de préférence environ 2% d'ADN hp (poids moléculaire supérieur à 1 million), le reste étant de l'eau. Composition according to Claim 2, characterized in that the biocomplex is formed from 4 to 12% by weight, preferably approximately 8%, of placental extract, for example bovine or sheep, from 4 to 12%, preferably approximately 8% , thymic peptides, for example of calves, from 0.5 to 3%, preferably about 2% of hp DNA (molecular weight greater than 1 million), the remainder being water. 4. Composition selon l'une des revendications 1 à 3, caractérisée par le fait qu'elle comporte un mélange de composés aromatiques (CA) contenant des essences de girofle, de rose, de bois de cèdre, de géranium, de patchouli, de bois de santal et de bois de rose, ainsi que des absolues de vanille et de jasmin. 4. Composition according to one of claims 1 to 3, characterized in that it comprises a mixture of aromatic compounds (CA) containing essences of clove, rose, cedarwood, geranium, patchouli, sandalwood and rosewood, as well as vanilla and jasmine absolutes. 5. 5. Composition selon la revendication 1, constituée par un gel, qui présente la formulation suivante: <tb><TABLE> Columns=3 <tb> <SEP>Composition: <SEP>BC <SEP>2,5% poids <tb> <SEP>Extrait de petit houx <SEP>0,25 <tb> <SEP>Extrait de marron d'Inde <SEP>0,25 <tb> <SEP>Alcool éthylique <SEP>2,0 <tb> <SEP>Polymère carboxyvinylique <SEP>0,8 <tb> <SEP>Composés aromatiques <SEP>0,06 <tb> <SEP>Huile de ricin hydrogénée <SEP>1,2 <tb> <SEP>Mélange de phénoxyéthanol et de méthyl-, éthyl-, propyl- et butylparabène <SEP>0,45 <tb> <SEP>Déhydroacétate de Na <SEP>0,1 <tb> <SEP>Lysine <SEP>1,2 <tb> <SEP>Cocoate de glycéryle-polyéthylèneglycol <SEP>3,0 <tb> <SEP>Diméthicone-copolyol <SEP>1,0 <tb> <SEP>Colorant <SEP>0,012 <tb> <SEP>Eau déminéralisée <SEP>ad. 100 <tb></TABLE> 1. Composition cosmétique défatigante comportant à titre de principes actifs un biocomplexe contenant un extrait placentaire, des peptides thymiques et de l'acide désoxyribonucléique hautement polymérisé, ainsi qu'un mélange d'extraits de végétaux contenant des flavonoïdes et des saponines. 2. Composition selon la revendication 1, caractérisée par le fait qu'elle comporte de 1 à 5% poids du biocomplexe, de préférence environ 2,5%, de 0,1 à 1% poids d'extrait de marron d'Inde contenant des flavonoïdes, de préférence environ 0,25%, et de 0,1 à 1% poids d'extrait de petit houx (=ruscus) contenant des saponines, de préférence environ 0,25%. 3.  Composition according to Claim 1, consisting of a gel, which has the following formulation: <tb> <TABLE> Columns = 3 <tb> <SEP> Composition: <SEP> BC <SEP> 2.5% by weight <tb> <SEP> Small holly extract <SEP> 0.25 <tb> <SEP> Horse chestnut extract <SEP> 0.25 <tb> <SEP> Ethyl alcohol <SEP> 2.0 <tb> <SEP> Carboxyvinyl polymer <SEP> 0.8 <tb> <SEP> Aromatic compounds <SEP> 0.06 <tb> <SEP> Hydrogenated castor oil <SEP> 1,2 <tb> <SEP> Mixture of phenoxyethanol and methyl-, ethyl-, propyl- and butylparaben <SEP> 0.45 <tb> <SEP> Na dehydroacetate <SEP> 0.1 <tb> <SEP> Lysine <SEP> 1,2 <tb> <SEP> Glyceryl-polyethylene glycol cocoate <SEP> 3.0 <tb> <SEP> Dimethicone-copolyol <SEP> 1.0 <tb> <SEP> Dye <SEP> 0.012 <tb> <SEP> Demineralized water <SEP> ad. 100 <tb> </TABLE>       1. Anti-fatigue cosmetic composition comprising as active principles a biocomplex containing a placental extract, thymic peptides and highly polymerized deoxyribonucleic acid, as well as a mixture of plant extracts containing flavonoids and saponins. 2. Composition according to claim 1, characterized in that it comprises from 1 to 5% by weight of the biocomplex, preferably about 2.5%, from 0.1 to 1% by weight of horse chestnut extract containing flavonoids, preferably about 0.25%, and 0.1 to 1% by weight of small holly extract (= ruscus) containing saponins, preferably about 0.25%. 3. Composition selon la revendication 2, caractérisée par le fait que le biocomplexe est formé de 4 à 12% poids, de préférence environ 8%, d'extrait placentaire, par exemple bovin ou ovin, de 4 à 12%, de préférence environ 8%, de peptides thymiques, par exemple de veaux, de 0,5 à 3%, de préférence environ 2% d'ADN hp (poids moléculaire supérieur à 1 million), le reste étant de l'eau. 4. Composition selon l'une des revendications 1 à 3, caractérisée par le fait qu'elle comporte un mélange de composés aromatiques (CA) contenant des essences de girofle, de rose, de bois de cèdre, de géranium, de patchouli, de bois de santal et de bois de rose, ainsi que des absolues de vanille et de jasmin. 5. Composition according to Claim 2, characterized in that the biocomplex is formed from 4 to 12% by weight, preferably approximately 8%, of placental extract, for example bovine or sheep, from 4 to 12%, preferably approximately 8% , thymic peptides, for example of calves, from 0.5 to 3%, preferably about 2% of hp DNA (molecular weight greater than 1 million), the remainder being water. 4. Composition according to one of claims 1 to 3, characterized in that it comprises a mixture of aromatic compounds (CA) containing essences of clove, rose, cedarwood, geranium, patchouli, sandalwood and rosewood, as well as vanilla and jasmine absolutes. 5. Composition selon la revendication 1, constituée par un gel, qui présente la formulation suivante: <tb><TABLE> Columns=3 <tb> <SEP>Composition: <SEP>BC <SEP>2,5% poids <tb> <SEP>Extrait de petit houx <SEP>0,25 <tb> <SEP>Extrait de marron d'Inde <SEP>0,25 <tb> <SEP>Alcool éthylique <SEP>2,0 <tb> <SEP>Polymère carboxyvinylique <SEP>0,8 <tb> <SEP>Composés aromatiques <SEP>0,06 <tb> <SEP>Huile de ricin hydrogénée <SEP>1,2 <tb> <SEP>Mélange de phénoxyéthanol et de méthyl-, éthyl-, propyl- et butylparabène <SEP>0,45 <tb> <SEP>Déhydroacétate de Na <SEP>0,1 <tb> <SEP>Lysine <SEP>1,2 <tb> <SEP>Cocoate de glycéryle-polyéthylèneglycol <SEP>3,0 <tb> <SEP>Diméthicone-copolyol <SEP>1,0 <tb> <SEP>Colorant <SEP>0,012 <tb> <SEP>Eau déminéralisée <SEP>ad. 100 <tb></TABLE>  Composition according to Claim 1, consisting of a gel, which has the following formulation: <tb> <TABLE> Columns = 3 <tb> <SEP> Composition: <SEP> BC <SEP> 2.5% by weight <tb> <SEP> Small holly extract <SEP> 0.25 <tb> <SEP> Horse chestnut extract <SEP> 0.25 <tb> <SEP> Ethyl alcohol <SEP> 2.0 <tb> <SEP> Carboxyvinyl polymer <SEP> 0.8 <tb> <SEP> Aromatic compounds <SEP> 0.06 <tb> <SEP> Hydrogenated castor oil <SEP> 1,2 <tb> <SEP> Mixture of phenoxyethanol and methyl-, ethyl-, propyl- and butylparaben <SEP> 0.45 <tb> <SEP> Na dehydroacetate <SEP> 0.1 <tb> <SEP> Lysine <SEP> 1,2 <tb> <SEP> Glyceryl-polyethylene glycol cocoate <SEP> 3.0 <tb> <SEP> Dimethicone-copolyol <SEP> 1.0 <tb> <SEP> Dye <SEP> 0.012 <tb> <SEP> Demineralized water <SEP> ad. 100 <tb> </TABLE>  
CH1931/89A 1989-05-23 1989-05-23 Cosmetic compsn. for reviving skin - contg. placental extract, thymus peptide(s) high mol.wt. DNA, flavonoid(s) and saponin(s) CH678487A5 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH1931/89A CH678487A5 (en) 1989-05-23 1989-05-23 Cosmetic compsn. for reviving skin - contg. placental extract, thymus peptide(s) high mol.wt. DNA, flavonoid(s) and saponin(s)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1931/89A CH678487A5 (en) 1989-05-23 1989-05-23 Cosmetic compsn. for reviving skin - contg. placental extract, thymus peptide(s) high mol.wt. DNA, flavonoid(s) and saponin(s)

Publications (1)

Publication Number Publication Date
CH678487A5 true CH678487A5 (en) 1991-09-30

Family

ID=4221943

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1931/89A CH678487A5 (en) 1989-05-23 1989-05-23 Cosmetic compsn. for reviving skin - contg. placental extract, thymus peptide(s) high mol.wt. DNA, flavonoid(s) and saponin(s)

Country Status (1)

Country Link
CH (1) CH678487A5 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624673A (en) * 1991-06-04 1997-04-29 Lymh Recherche Cosmetic or pharmaceutical composition containing a prunella extract
BG65639B1 (en) * 2004-06-25 2009-04-30 Диана СТЕФАНОВА Regeneration composition
US20110217395A1 (en) * 2010-03-04 2011-09-08 Komeh-Nkrumah Steva A Therapeutic, Bio-Affecting And Body Treating Composition
CN104053425A (en) * 2012-01-16 2014-09-17 阿詹特姆控股有限责任公司 Dermocosmetic compositions based on synergistic combination of colloidal silver and deoxyribonucleic acid

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624673A (en) * 1991-06-04 1997-04-29 Lymh Recherche Cosmetic or pharmaceutical composition containing a prunella extract
BG65639B1 (en) * 2004-06-25 2009-04-30 Диана СТЕФАНОВА Regeneration composition
US20110217395A1 (en) * 2010-03-04 2011-09-08 Komeh-Nkrumah Steva A Therapeutic, Bio-Affecting And Body Treating Composition
US8821948B2 (en) * 2010-03-04 2014-09-02 Steva A. Komeh-Nkrumah Therapeutic, bio-affecting and body treating composition
CN104053425A (en) * 2012-01-16 2014-09-17 阿詹特姆控股有限责任公司 Dermocosmetic compositions based on synergistic combination of colloidal silver and deoxyribonucleic acid
US20140356436A1 (en) * 2012-01-16 2014-12-04 Argentum Holding Sàrl Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid
CN104053425B (en) * 2012-01-16 2016-10-05 阿詹特姆药剂有限公司 Medical science skin care compositions based on collargol and the synergistic combination of DNA (deoxyribonucleic acid)
US9486397B2 (en) * 2012-01-16 2016-11-08 Argentum Holdings S.A.R.L. Dermocosmetic compositions based on a synergistic combination of colloidal silver and deoxyribonucleic acid

Similar Documents

Publication Publication Date Title
EP1112057B1 (en) Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution)
EP2496242B1 (en) Use of yeast peptide hydrolysate as an active agent for strengthening hair
FR2802425A1 (en) Cosmetic compositions for combating aging of the skin or exoskeleton contain extract of Vaccinium genus plant as glycation inhibitor
FR2843023A1 (en) COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING KOMBUCHA.
FR2768621A1 (en) Use of extract of Rosaceae as substance P antagonist to treat skin disorders, inflammation etc.
FR2799369A1 (en) COMBINATION OF ESCINE AND DEXTRAN SULFATE AND THE USE THEREOF
FR2594691A1 (en) NEW COSMETIC PREPARATIONS CONTAINING AN EXTRACT OF SILYBUM MARIANUM FRUITS
EP0770381B1 (en) Support and composition containing it together with a stabilised cosmetic or dermatologic agent
EP0909556B1 (en) Rosaceae extract as bradykinin antagonist
EP1250124A2 (en) Slimming cosmetic composition comprising as active agent a plant extract containing a plant natriuretic peptide (pnp)
FR2808191A1 (en) PLANT EXTRACT FROM THE OLEA EUROPAEA SPECIES AS A NO-SYNTHASE INHIBITOR AND USES
CH678487A5 (en) Cosmetic compsn. for reviving skin - contg. placental extract, thymus peptide(s) high mol.wt. DNA, flavonoid(s) and saponin(s)
FR2775594A1 (en) USE OF A COMPOUND INHIBITING THE ACTIVITY OF A SODIUM CHANNEL OR A CALCIUM CHANNEL IN A TOPICAL USE COMPOSITION
CH678489A5 (en) Cosmetic compsn. contg. placental extract, thymus peptide(s) and DNA - plus flavonoid contg. plant extracts, for improving metabolism, replication and micro-circulation of skin and protecting against ageing
FR2807321A1 (en) Cosmetic, dermatological or pharmaceutical formulation especially useful for protection of hair, contain synergistic combination of N-acylated aminoacid and panthenol compounds
FR2827171A1 (en) Use of an enzymatic hydrolysate of salmon eggs for preventing or treating the effects of aging caused by physiology or sunlight
US20130225504A1 (en) Use of a corn peptidic hydrolyzate as an active agent stiimulating hair growth
RU2183954C1 (en) Cosmetic agent for complex skin care and method of its application
RU2212229C1 (en) Diurnal recovering cream
RU2184528C1 (en) Cooling cosmetic gel
JPH09227397A (en) Preparation for external use for skin
RU2298398C2 (en) Cosmetic cream
JP2024086182A (en) Skin penetration enhancer for royal jelly
RU2236841C1 (en) Cosmetic preparation for taking care of problematic facial skin
FR2856296A1 (en) COSMETIC CARE PROCESS WHICH COMBINES A MECHANICAL EFFECT, RESULTING FROM A MASSAGE, WITH BIOLOGICAL EFFECTS IN COMPLEMENT OR RELAY

Legal Events

Date Code Title Description
PL Patent ceased